Mehul Suthar
Overview
Explore the profile of Mehul Suthar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
388
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hatabah D, Gupta S, Mantus G, Sullivan P, Heilman S, Camacho-Gonzalez A, et al.
Vaccines (Basel)
. 2025 Feb;
13(2).
PMID: 40006710
Vaccines against COVID-19 target the spike protein. There is minimal information on longitudinal COVID-19 immune profiling in recovered versus naïve and vaccinated versus non-vaccinated healthcare workers (HCWs). This is a...
2.
Rostad C, Yildirim I, Kao C, Yi J, Kamidani S, Peters E, et al.
NPJ Vaccines
. 2024 Dec;
9(1):255.
PMID: 39715748
Filoviruses, including Ebola, Marburg, Sudan, and Taï Forest viruses, are zoonotic pathogens that can cause severe viral hemorrhagic fever and death. Developing vaccines that provide durable, broad immunity against multiple...
3.
Griffiths M, Hatabah D, Sullivan P, Mantus G, Sanchez T, Zlotorzynska M, et al.
Int J Infect Dis
. 2024 Nov;
149:107278.
PMID: 39515078
No abstract available.
4.
Suthar M, Mishra D, Juneja M, Kalra B, Arya Y
Indian Pediatr
. 2024 Jul;
61(8):768-770.
PMID: 39001784
We determined the burden of concomitant chronic non-epilepsy drug use in 100 consecutive outpatient children with a diagnosis of epilepsy (mean (SD) age 7.38 (3.24) y), taking anti-seizure medications (ASM)...
5.
Boon J, Soudani N, Bricker T, Darling T, Seehra K, Patel N, et al.
Res Sq
. 2024 Feb;
PMID: 38405749
The continued emergence of SARS-CoV-2 variants necessitates updating COVID-19 vaccines to match circulating strains. The immunogenicity and efficacy of these vaccines must be tested in pre-clinical animal models. In Syrian...
6.
Muhlemann B, Wilks S, Baracco L, Bekliz M, Carreno J, Corman V, et al.
bioRxiv
. 2023 Oct;
PMID: 37808679
The antigenic evolution of SARS-CoV-2 requires ongoing monitoring to judge the immune escape of newly arising variants. A surveillance system necessitates an understanding of differences in neutralization titers measured in...
7.
Medina A, Rusnak R, Richardson R, Zimmerman M, Suthar M, Schoof N, et al.
J Neuroimmunol
. 2023 Jul;
381:578148.
PMID: 37451078
Zika virus (ZIKV) infection during infancy in a rhesus macaque (RM) model negatively impacts brain development resulting in long-term behavioral alterations. The current study investigated whether postexposure prophylaxis could alleviate...
8.
Yu J, Thomas P, Sciacca M, Wu C, Liu J, He X, et al.
Cell Rep Med
. 2023 Apr;
4(4):101018.
PMID: 37023746
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines demonstrate reduced protection against acquisition of BA.5 subvariant but are still effective against severe disease. However, immune correlates of protection against BA.5...
9.
Goodrum F, Lowen A, Lakdawala S, Alwine J, Casadevall A, Imperiale M, et al.
mSphere
. 2023 Jan;
8(2):e0003423.
PMID: 36700653
Viruses have brought humanity many challenges: respiratory infection, cancer, neurological impairment and immunosuppression to name a few. Virology research over the last 60+ years has responded to reduce this disease...
10.
Goodrum F, Lowen A, Lakdawala S, Alwine J, Casadevall A, Imperiale M, et al.
mBio
. 2023 Jan;
14(1):e0018823.
PMID: 36700642
Viruses have brought humanity many challenges: respiratory infection, cancer, neurological impairment and immunosuppression to name a few. Virology research over the last 60+ years has responded to reduce this disease...